Delivery Order SPE2DB20D9103-SPE2DB25FE7D9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $2,083.12 firm fixed-price delivery order by the Defense Logistics Agency for Mirena 52 mg contraceptive systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a specific purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order for 52 mg Mirena systems valued at $2,083.12 by the Defense Logistics Agency (DLA). Issued on August 1, 2025, with an ultimate completion date of August 22, 2025, this firm fixed-price delivery order is being performed at the contractor's facility in Park Ridge, Illinois. The award utilized no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $2,083.12 from the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract calls for the delivery of Mirena 52 mg contraceptive systems, with an ultimate completion date of August 11, 2025. This delivery order was issued without a set-aside designation and represents a single transaction under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,322.50 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, and is not designated under any specific set-aside program. The delivery will be performed at the vendor's Park Ridge, Illinois location. This...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB25FE7D9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,083.12 for Mirena 52 mg systems by the Defense Logistics Agency (DLA). This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a specific task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its woman-owned small business status. Mirena is a contraceptive implant system used in military and federal healthcare facilities, consistent with DMS Pharmaceutical Group's core business of supplying pharmaceutical products and medical consumables to Department of Defense healthcare sites nationwide. This delivery order is part of DMS Pharmaceutical Group's strategic positioning within the federal pharmaceutical supply chain through its $500 million single-award IDC with the DLA under the SPE2DB program, valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders across a comprehensive range of pharmaceutical items, branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group has demonstrated consistent success in securing federal contracts with the DLA, leveraging its woman-owned small business classification and established capabilities in pharmaceutical distribution to support critical healthcare requirements across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/7/25 |